CLINICAL_TRIALS
trial_result
· 2011-07-06
Clinical Trial Update: Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan [Phase 2]
Summary
Phase 2 trial evaluating the efficacy and safety of alogliptin in Japanese participants with type 2 diabetes; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2011-07-06